Comparison of quality of life and activity of daily living status of patients with myasthenia gravis treated with low-dose and high-dose prednisolone.

Katsuki, Masaaki; Sugahara, Hirotaka; Kojima, Yuka; Yamashita, Kanae; Moriuchi, Hiroshi; Kubota, Toshio; Masuda, Masayuki; Irikura, Mitsuru

Katsuki, Masaaki; Sugahara, Hirotaka; Kojima, Yuka; Yamashita, Kanae; Moriuchi, Hiroshi; Kubota, Toshio; Masuda, Masayuki; Irikura, Mitsuru.

Afiliação

Katsuki M; Center of Pharmaceutical Care for Community Health, Daiichi University of Pharmacy, Fukuoka, Japan.
Sugahara H; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan.
Kojima Y; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan.
Yamashita K; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan.
Moriuchi H; Center of Pharmaceutical Care for Community Health, Daiichi University of Pharmacy, Fukuoka, Japan.
Kubota T; Center of Pharmaceutical Care for Community Health, Daiichi University of Pharmacy, Fukuoka, Japan.
Masuda M; Department of Neurology, Tokyo Medical University, Tokyo, Japan.
Irikura M; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan.

Neuro Endocrinol Lett ; 41(4): 173-178, 2020 Oct.

Article em En | MEDLINE | ID: mdl-33307652

Assuntos

Miastenia Gravis; Qualidade de Vida; Atividades Cotidianas; Humanos; Miastenia Gravis/tratamento farmacológico; Prednisolona; Inquéritos e Questionários

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Miastenia Gravis Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Neuro Endocrinol Lett Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Suécia

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

PubMed Links